Laiminga uodega, MB

Company age: 4 y. 10 mo.

Update

Company overview

Company name Laiminga uodega, MB
Company code 305941359
VAT code LT100016360114
Registered address Kauno r. sav., Ringaudų sen., Noreikiškių k., Šiltnamių g. 38, LT-53363
Registration date 2021-11-22 Company age: 4 y. 10 mo.
Phone Phone
Email Email
Company manager For registered members only Log in
Revenue (2025) 221,722 € +94% History
Profit (2025) 7,655 € +370% History
Number of employees 0
Managed vehicles 1 List
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Small partnership
NACE activity Retail sale of pharmaceutical products
Ownership form Private without foreign capital
Managed brands 1 List

Download a detailed company report

Make confident decisions with all the information about Laiminga uodega, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report

Description

This description was generated by artificial intelligence.
Laiminga uodega, MB (company code 305941359) is an operational private small partnership registered in 2021. It belongs to the national private non-financial companies sector and is described as privately owned, with more than 50% of authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. Governance is CEO only, and the company is classified as micro. Its core activity under EVRK code G.47.73.00 is retail sale of pharmaceutical products.

The company is based in Noreikiškiu k., Ringaudu sen., Kauno r. sav., Kauno County. Financial results show strong growth in recent years. Revenue increased from EUR 53.5 thousand in 2023 to EUR 114.3 thousand in 2024 and reached EUR 221.7 thousand in 2025. After a net loss of EUR 1.9 thousand in 2023, the company returned to profitability in 2024 with net profit of EUR 1.6 thousand and improved further to EUR 7.7 thousand in 2025. Profit margin rose from -3.6% in 2023 to 1.4% in 2024 and 3.5% in 2025. Equity turned positive in 2025 at EUR 5.8 thousand, while total assets increased to EUR 33.3 thousand.